Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Chi Sheng Pharma & Biotech Co., Ltd. (4111) Financial Statements

Chi Sheng Pharma & Biotech Co., Ltd. Financial Overview

Chi Sheng Pharma & Biotech Co., Ltd.'s market cap is currently NT$1.71B. The company's EPS TTM is NT$3.15; its P/E ratio is 9.16; and it has a dividend yield of 4.56%. Chi Sheng Pharma & Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.38BNT$ 1.17BNT$ 1.06BNT$ 1.14BNT$ 1.02B
Gross ProfitNT$ 507.61MNT$ 397.18MNT$ 343.10MNT$ 422.51MNT$ 356.58M
Operating IncomeNT$ 199.30MNT$ 98.95MNT$ 61.21MNT$ 163.81MNT$ 132.87M
EBITDANT$ 271.75MNT$ 204.56MNT$ 150.75MNT$ 236.69MNT$ 211.94M
Net IncomeNT$ 164.28MNT$ 110.63MNT$ 68.67MNT$ 154.01MNT$ 80.75M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 443.91MNT$ 336.19MNT$ 381.05MNT$ 456.25MNT$ 252.27M
Total AssetsNT$ 1.94BNT$ 1.75BNT$ 1.77BNT$ 1.80BNT$ 1.66B
Total DebtNT$ 48.77MNT$ 185.94MNT$ 122.90MNT$ 290.38MNT$ 292.20M
Net DebtNT$ -395.14MNT$ -150.25MNT$ -258.15MNT$ -165.88MNT$ 39.93M
Total LiabilitiesNT$ 557.04MNT$ 475.08MNT$ 547.04MNT$ 578.38MNT$ 559.04M
Stockholders' EquityNT$ 1.38BNT$ 1.27BNT$ 1.22BNT$ 1.22BNT$ 1.10B
Cash Flow
Free Cash FlowNT$ 315.19MNT$ 127.98MNT$ -26.98MNT$ 109.00MNT$ -126.18M
Operating Cash FlowNT$ 409.05MNT$ 213.20MNT$ 74.52MNT$ 214.86MNT$ 139.33M
Investing Cash FlowNT$ -97.17MNT$ -86.31MNT$ -76.61MNT$ 63.24MNT$ -289.02M
Financing Cash FlowNT$ -204.17MNT$ -171.75MNT$ -73.11MNT$ -74.88MNT$ 66.68M

Currency in TWD

Chi Sheng Pharma & Biotech Co., Ltd. Earnings and Revenue History

0500M1B1.5B4 %8 %12 %16 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Chi Sheng Pharma & Biotech Co., Ltd. Liabilities to Assets

0800M1.6B2.4B24 %28 %32 %36 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Chi Sheng Pharma & Biotech Co., Ltd. Cash Flow

-400M-200M0200M400M600M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Chi Sheng Pharma & Biotech Co., Ltd. Forecast EPS vs Actual EPS

0.50.60.70.80.91Q2 25Q3 25Q4 25Q1 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >